Drug Approval | June 01, 2022
FDA approves Roche’s Evrysdi for use in babies under two months with SMA
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
The ABDM public dashboard is a one-stop solution for information on the mission’s progress up to state/UT level
The revamped Ayushman Bharat Health Account (ABHA) mobile application offers added functionalities and a new User Interface (UI)
They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugate (AIAC) both with global intellectual property rights
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
Cipla has reported consolidated financial results for the period ended March 31, 2022
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The report has estimated 4.74 million deaths for India in 2020 and 2021,
Revolution Aspire CT System is manufactured at the company’s new plant launched under the government’s Production Linked Incentives (PLI) Scheme
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
Subscribe To Our Newsletter & Stay Updated
